CLINICAL_TRIALS
trial_result
· 2015-03-12
Clinical Trial Update: A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis. [Phase 4]
Summary
A Phase 4 trial evaluated Rituximab (MabThera) using MRI to assess treatment in rheumatoid arthritis; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2015-03-12